HK Stock Market Move | CRYSTAL INTL (02232) surged over 5% after earnings, with interim shareholder profit attributable to shareholders increasing by 10.6% year-on-year. The expansion of the factory in Egypt is expected to contribute additional volume.
Jingyuan International (02232) rose more than 5% after its results, and as of the time of publication, it is up 4.99%, trading at HKD 7.265, with a turnover of HKD 43.0102 million.
CRYSTAL INTL (02232) has risen over 5% after its earnings report, and as of the time of writing, it is up 4.99%, trading at HKD 7.265, with a turnover of HKD 43.01 million.
In terms of news, on August 19, CRYSTAL INTL released its performance for the six months ending June 30, 2026, reporting revenue of USD 1.296 billion, a year-on-year increase of 5.4%; profit attributable to the owners of the company was USD 109 million, up 10.6%; basic earnings per share were 3.81 US cents, and a mid-term dividend of 18 HK cents per share is proposed. The announcement stated that in the first half of 2026, the group continued to benefit from strong order growth from brand customers, and the impact from conflicts in the Middle East was relatively minor. Thus, the group's revenue and profitability achieved robust growth during the period.
Huaxi noted that CRYSTAL INTL's capital expenditure for the first half of 2026 was USD 112 million, a year-on-year increase of 86.7%. The increase in capital expenditure was primarily due to the company's strategic expansion project in Egypt, which included a one-off payment made during the reporting period for the acquisition of a plot in New October City, Egypt. The total area of the plot is approximately 800,000 square meters, and the acquisition cost was USD 30.4 million, laying the foundation for the company's manufacturing development project in Egypt, which is also a significant milestone in the company's long-term capacity expansion strategy. The Egyptian base is close to Europe and is expected to serve European customers more conveniently once operational, becoming a new driver of growth.
Related Articles

AAC TECH (02018) released its mid-term performance report, with a net profit of 901 million yuan, an increase of 2.9% year-on-year, and revenue reaching a new high of 14.51 billion yuan.

SSY GROUP (02005) has obtained the drug production registration certificate for Vitamin K1 injection (1ml: 10mg).

HK Stock Market Move | CHINA BLUECHEM (03983) fell over 9% after earnings report, with net profit in the first half down more than 20% year-on-year. The pressure on profits is unlikely to ease in the short term.
AAC TECH (02018) released its mid-term performance report, with a net profit of 901 million yuan, an increase of 2.9% year-on-year, and revenue reaching a new high of 14.51 billion yuan.

SSY GROUP (02005) has obtained the drug production registration certificate for Vitamin K1 injection (1ml: 10mg).

HK Stock Market Move | CHINA BLUECHEM (03983) fell over 9% after earnings report, with net profit in the first half down more than 20% year-on-year. The pressure on profits is unlikely to ease in the short term.

RECOMMEND





